Peer-reviewedCC BYInternational journal of pharmaceutics: X
Finerenone liposome-embedded dissolving microneedles: A transcorneal platform for minimally invasive therapy of diabetic retinopathy
- 1First Affiliated Hospital of Huzhou Normal University, Huzhou, Zhejiang, 313000, China
- 2College of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China
- 3Affiliated Huzhou Central Hospital, Huzhou University, Huzhou, Zhejiang, 313000, China
Related
- Propolis-Based Microneedles Incorporating Neratinib-Loaded Ocimum basilicum Essential Oil-Based Lipid Nanovesicles for Minimally Invasive Cancer Therapy: Formulation and In Vivo Evaluation in an Ehrlich Solid Tumor Model.
- Transdermal Delivery of an Adjuvanted SARS-CoV-2 Triple RBD Subunit Vaccine in Mice Using Dissolving Microneedle Array Patch
- Dissolving hyaluronic acid microparticles improve skin barrier function, hydration, and elasticity in a randomized split-face clinical trial
- Naringenin microneedles as theranostics in the management of rheumatoid arthritis
- A constraint dissolving method for generally constrained optimization over a nonconvex set
BibTeX
@article{zhang2026finerenone,
title = {{Finerenone liposome-embedded dissolving microneedles: A transcorneal platform for minimally invasive therapy of diabetic retinopathy}},
author = {Weili Zhang and Lu Wang and Wen Qin and Yingrong Chen and Shenyun Fang and Zhenchao Ma and Tao Xue and Xiang Yu},
journal = {International journal of pharmaceutics: X},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13691493},
note = {CC BY},
}
RIS
TY - JOUR
TI - Finerenone liposome-embedded dissolving microneedles: A transcorneal platform for minimally invasive therapy of diabetic retinopathy
AU - Weili Zhang
AU - Lu Wang
AU - Wen Qin
AU - Yingrong Chen
AU - Shenyun Fang
AU - Zhenchao Ma
AU - Tao Xue
AU - Xiang Yu
PY - 2026
DA - 2026/10/13
JO - International journal of pharmaceutics: X
UR - https://europepmc.org/article/PMC/PMC13691493
SN - 2590-1567
ER -